Related references
Note: Only part of the references are listed.Deferasirox at therapeutic doses is associated with dose-dependent hypercalciuria
Phillip Wong et al.
BONE (2016)
Klotho, a new marker for osteoporosis and muscle strength in β-thalassemia major
Alessandro Baldan et al.
BLOOD CELLS MOLECULES AND DISEASES (2015)
Erythropoietin directly stimulates osteoclast precursors and induces bone loss
Sahar Hiram-Bab et al.
FASEB JOURNAL (2015)
Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
Benjamin Z. Leder et al.
LANCET (2015)
Effects of teriparatide retreatment in a patient with β-thalassemia major
Symeon Tournis et al.
TRANSFUSION (2015)
Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort study
Daojun Mo et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major
Maddalena Casale et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis
Erik F. Eriksen et al.
BONE (2014)
Variance of pain prevalence and associated severity during the transfusion cycle of adult thalassaemia patients
Sage T. Green et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Hepcidin1 Knockout Mice Display Defects in Bone Microarchitecture and Changes of Bone Formation Markers
Guang Si Shen et al.
CALCIFIED TISSUE INTERNATIONAL (2014)
Spine Bone Texture Assessed by Trabecular Bone Score (TBS) to Evaluate Bone Health in Thalassemia Major
M. Baldini et al.
CALCIFIED TISSUE INTERNATIONAL (2014)
Thalassemia Bone Disease: A 19-Year Longitudinal Analysis
Phillip Wong et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Bone Histomorphometry of Transiliac Paired Bone Biopsies After 6 or 12 Months of Treatment With Oral Strontium Ranelate in 387 Osteoporotic Women: Randomized Comparison to Alendronate
Pascale Chavassieux et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Fracture Prediction and the Definition of Osteoporosis in Children and Adolescents: The ISCD 2013 Pediatric Official Positions
Nick Bishop et al.
JOURNAL OF CLINICAL DENSITOMETRY (2014)
Serum Dickkopf 1 Levels in Sclerostin Deficiency
A. H. van Lierop et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Type 2 diabetes mellitus and fracture risk
Anastasia D. Dede et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Calcium supplement intake and risk of cardiovascular disease in women
J. M. Paik et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Bisphosphonate therapy in pediatric patients
Guiti Eghbali-Fatourechi
JOURNAL OF DIABETES AND METABOLIC DISORDERS (2014)
Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial
Ellen B. Fung et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)
Pain over time and its effects on life in thalassemia
Olivia Oliveros et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Pain in thalassaemia: the effects of age on pain frequency and severity
Dru Haines et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Comparison of Serum Dkk1 (Dickkopf-1) and Bone Mineral Density in Patients on Bisphosphonate Treatment Vs no Treatment
Adeel R. Memon et al.
JOURNAL OF CLINICAL DENSITOMETRY (2013)
The Ability of Lumbar Spine DXA and Phalanx QUS to Detect Previous Fractures in Young Thalassemic Patients With Hypogonadism, Hypothyroidism, Diabetes, and Hepatitis-B: A 2-Year Subgroup Analysis From the Taranto Area of Apulia Region
Alberto Argentiero et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2013)
Unrecognized Vertebral Fractures in Adolescents and Young Adults With Thalassemia Syndromes
Pontipa Engkakul et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2013)
Thalassemia bone disease: the association between nephrolithiasis, bone mineral density and fractures
P. Wong et al.
OSTEOPOROSIS INTERNATIONAL (2013)
A Prospective Study of Tubular Dysfunction in Pediatric Patients with Beta Thalassemia Major Receiving Deferasirox
Majid Naderi et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2013)
A national registry of haemoglobinopathies in Greece: Deducted demographics, trends in mortality and affected births
Ersi Voskaridou et al.
ANNALS OF HEMATOLOGY (2012)
Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study
Gian Luca Forni et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Prospective study of histomorphometry, biochemical bone markers and bone densitometric response to pamidronate in β-thalassaemia presenting with osteopenia-osteoporosis syndrome
Ratna Chatterjee et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
High Circulating Sclerostin is Present in Patients with Thalassemia-associated Osteoporosis and Correlates with Bone Mineral Density
E. Voskaridou et al.
HORMONE AND METABOLIC RESEARCH (2012)
The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
Dennis M. Black et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women-the six-month effect of risedronate and teriparatide
S. A. Polyzos et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Osteoporosis in young adults: pathophysiology, diagnosis, and management
S. Ferrari et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Thyroid hormone metabolism in skeletal development and adult bone maintenance
Julian A. Waung et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Hypercoagulability in β-thalassemia: a status quo
Maria Domenica Cappellini et al.
EXPERT REVIEW OF HEMATOLOGY (2012)
Treatment of vitamin D deficiency in transfusion-dependent thalassemia
Ellen B. Fung et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Vitamin D With or Without Calcium Supplementation for Prevention of Cancer and Fractures: An Updated Meta-analysis for the US Preventive Services Task Force
Mei Chung et al.
ANNALS OF INTERNAL MEDICINE (2011)
Characterization of low bone mass in young patients with thalassemia by DXA, pQCT and markers of bone turnover
Ellen B. Fung et al.
BONE (2011)
Renal dysfunction in patients with thalassaemia
Charles T. Quinn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Safety of Long-Term Bisphosphonate Therapy for the Management of Osteoporosis
E. Michael Lewiecki
DRUGS (2011)
Calcium Supplementation and the Risks of Atherosclerotic Vascular Disease in Older Women: Results of a 5-Year RCT and a 4.5-Year Follow-up
Joshua R. Lewis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Inhibitory Effects of Iron on Bone Morphogenetic Protein 2-Induced Osteoblastogenesis
Qing Yang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Physiologic Estrogen Replacement Increases Bone Density in Adolescent Girls With Anorexia Nervosa
Madhusmita Misra et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Quantitative Computed Tomography Is Unreliable for Measurement of Bone Mineral Density in Inadequately Chelated Adolescent Patients With β-Thalassemia Major: A Case-Control Study
Deepak Bansal et al.
PEDIATRIC BLOOD & CANCER (2011)
Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis
Mark J. Bolland et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major
Marina Baldini et al.
ANNALS OF HEMATOLOGY (2010)
Nutritional deficiencies in patients with thalassemia
Ellen B. Fung
COOLEY'S ANEMIA: NINTH SYMPOSIUM (2010)
Acidosis, hypoxia and bone
Timothy R. Arnett
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Renal complications in transfusion-dependent beta thalassaemia
Claudio Ponticelli et al.
BLOOD REVIEWS (2010)
Relationship between Chronic Transfusion Therapy and Body Composition in Subjects with Thalassemia
Ellen B. Fung et al.
JOURNAL OF PEDIATRICS (2010)
Poor correlations between measurements of bone quality by quantitative ultrasound sonography and dual energy X-ray absorptiometry in patients with beta-thalassaemia major
Athanasios Christoforidis et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration
Ersi Voskaridou et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
LONG-TERM EFFECTS OF PAMIDRONATE IN THALASSEMIC PATIENTS WITH SEVERE BONE MINERAL DENSITY DEFICITS
Ting Fan Leung et al.
HEMOGLOBIN (2009)
Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem
Maria G. Vogiatzi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS)
Richard Eastell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia
B. Fung Ellen et al.
BONE (2008)
Global epidemiology of haemoglobin disorders and derived service indicators
Bernadette Modell et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
Bone demineralization in adult thalassaemic patients: contribution of GH and IGF-I at different skeletal sites
Massimo Scacchi et al.
CLINICAL ENDOCRINOLOGY (2008)
Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial
Ersi Voskaridou et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Could transdermal estradiol plus progesterone be a safer postmenopausal HRT? A review
Marc L'Hermite et al.
MATURITAS (2008)
Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis
Benjamin M. P. Tang et al.
LANCET (2007)
Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload
Ellen B. Fung et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Markers of bone metabolism in eugonadal female patients with β-thalassemia major
Nicholas G. Angelopoulos et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2007)
A review of strontium ranelate and its effect on DXA scans
Glen M. Blake et al.
JOURNAL OF CLINICAL DENSITOMETRY (2007)
Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia
Vassilios Perifanis et al.
ANNALS OF HEMATOLOGY (2007)
Intravenous zoledronic acid treatment in thalassemia-induced osteoporosis: results of a phase II clinical trial
Zaher K. Otrock et al.
ANNALS OF HEMATOLOGY (2006)
A randomized, double-blind, placebo-controlled trial of intravenous zoledronic acid in the treatment of thalassemia-associated osteopenia
C. P. Gilfillan et al.
CALCIFIED TISSUE INTERNATIONAL (2006)
Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia
N. Napoli et al.
BONE (2006)
Prevalence of fractures among the Thalassemia syndromes in North America
MG Vogiatzi et al.
BONE (2006)
Hypoparathyroidism in transfusion-dependent patients with β-thalassemia
NG Angelopoulos et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2006)
Calcium plus vitamin D supplementation and the risk of fractures
RD Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Evaluation of bone mineral density of the lumbar spine in patients with β-thalassemia major with dual-energy X-ray absorptiometry and quantitative computed tomography -: A comparison study
NG Angelopoulos et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2006)
Comparison of DXA, QCT and trabecular structure in β-thalassaemia
M Mylona et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Complications of β-thalassemia major in north America
MJ Cunningham et al.
BLOOD (2004)
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle
N Morabito et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Growth hormone (GH) deficiency in patients with β-thalassemia major and the efficacy of recombinant GH treatment
KH Wu et al.
ANNALS OF HEMATOLOGY (2003)
Abnormalities in bone mineral density and bone histology in thalassemia
S Domrongkitchaiporn et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Bone histomorphometry in children and adolescents with β-thalassemia disease:: Iron-associated focal osteomalacia
P Mahachoklertwattana et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Impact of disordered puberty on bone density in beta-thalassaemia major
BK Bielinski et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia
E Voskaridou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Quantitative ultrasound of bone and clodronate effects in thalassemia-induced osteoporosis
P Pennisi et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2003)
Patterns of bone diseases in transfusion-dependent homozygous thalassaemia major: predominance of osteoporosis and desferrioxamine-induced bone dysplasia
YL Chan et al.
PEDIATRIC RADIOLOGY (2002)
Bisphosphonates in the treatment of thalassemia-induced osteoporosis
N Morabito et al.
OSTEOPOROSIS INTERNATIONAL (2002)
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major
A Lasco et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Bone resorption is increased in young adults with thalassaemia major
E Voskaridou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major
A Sartorio et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2000)
Share Paper
